ClinicalTrials.Veeva

Menu

RexMedical- Option* Vena Cava Filter IDE Study

R

Rex Medical

Status

Completed

Conditions

Pulmonary Embolism

Treatments

Device: Intravascular Filter Device

Study type

Interventional

Funder types

Industry

Identifiers

NCT00488865
REX-US-2006-001

Details and patient eligibility

About

This study is designed to evaluate the safety and efficacy of the RexMedical Option* Vena Cava Filter in the treatment of patients who are at increased risk for Pulmonary Embolism and require caval interruption.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Key Inclusion Criteria:

  • Patient is at least 18 years of age
  • Patient requires temporary or permanent caval interruption

Key Exclusion Criteria:

  • Patient has pre-existing filter implanted in her/her vasculature or has undergone filter retrieval within 60 days prior to study device implant
  • Patient is currently enrolled in another investigational device or drug trial

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

Intravascular Filter Device
Other group
Treatment:
Device: Intravascular Filter Device

Trial contacts and locations

10

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems